Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Chopra

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
RMD Open|January 5, 2018
Evaluation of the joint distribution at disease presentation of patients with rheumatoid arthritis: a large study across continentsSytske Anne Bergstra, Arvind Chopra, Manjit Saluja, et al.
Arthritis Research & Therapy|November 24, 2017
Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritisSytske Anne Bergstra, Cornelia F Allaart, Rosaline van den Berg, et al.
Frontiers in Medicine|March 7, 2022
Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study ProtocolArvind Chopra, Preeti Chavan-Gautam, Girish Tillu, et al.
Annals of the Rheumatic Diseases|May 25, 2023
Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registrySytske Anne Bergstra, Alexandre Sepriano, Arvind Chopra, et al.
Frontiers in Medicine|April 18, 2022
Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study ProtocolArvind Chopra, Preeti Chavan-Gautam, Girish Tillu, et al.
Annals of the Rheumatic Diseases|October 18, 2018
How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studiesSytske Anne Bergstra, Lai-Ling Winchow, Elizabeth Murphy, et al.
Rheumatology (Oxford, England)|February 4, 2021
Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practiceJohanna M Maassen, Sytske Anne Bergstra, Arvind Chopra, et al.
Rheumatology (Oxford, England)|February 1, 2013
Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trialArvind Chopra, Manjit Saluja, Girish Tillu, et al.
Rheumatology (Oxford, England)|September 12, 2018
Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritisJacqueline S Dekkers, Sytske Anne Bergstra, Arvind Chopra, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III studySyed Atiqul Haq, Fereydoun Davatchi, Saeideh Dahaghin, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
RMD Open|January 5, 2018
Evaluation of the joint distribution at disease presentation of patients with rheumatoid arthritis: a large study across continentsSytske Anne Bergstra, Arvind Chopra, Manjit Saluja, et al.
Arthritis Research & Therapy|November 24, 2017
Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritisSytske Anne Bergstra, Cornelia F Allaart, Rosaline van den Berg, et al.
Frontiers in Medicine|March 7, 2022
Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study ProtocolArvind Chopra, Preeti Chavan-Gautam, Girish Tillu, et al.
Annals of the Rheumatic Diseases|May 25, 2023
Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registrySytske Anne Bergstra, Alexandre Sepriano, Arvind Chopra, et al.
Frontiers in Medicine|April 18, 2022
Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study ProtocolArvind Chopra, Preeti Chavan-Gautam, Girish Tillu, et al.
Annals of the Rheumatic Diseases|October 18, 2018
How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studiesSytske Anne Bergstra, Lai-Ling Winchow, Elizabeth Murphy, et al.
Rheumatology (Oxford, England)|February 4, 2021
Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practiceJohanna M Maassen, Sytske Anne Bergstra, Arvind Chopra, et al.
Rheumatology (Oxford, England)|February 1, 2013
Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trialArvind Chopra, Manjit Saluja, Girish Tillu, et al.
Rheumatology (Oxford, England)|September 12, 2018
Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritisJacqueline S Dekkers, Sytske Anne Bergstra, Arvind Chopra, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III studySyed Atiqul Haq, Fereydoun Davatchi, Saeideh Dahaghin, et al.
Pageof 9